Results - Announcements
FDC Ltd share price inched up 2.36% to Rs 353.95. The Company's net profit witnessed a sharp fall of 62.97% to Rs 49.06 crore, while revenue from operations declined 14.31% to Rs 572.14 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.36%. It has marginally improved by 2.52% over last one week and dipped slightly by 0.63% in last one month while the market capitalization of FDC Ltd has improved by 2.97% and 14.57% in the same period respectively.
Profit before tax (PBT) of FDC Ltd stood at Rs 65.41 crore in Q3 FY26, expanding by 71.72% year-on-year, and plunging by 62.56% quarter-on-quarter. EBITDA came in at Rs 46 crore, jumping 251.67% YoY and nosediving by 51.38% sequentially.
Total expenses slightly declined by 2.96% to Rs 523.83 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 139.94 crore, slightly declining by 3.16% YoY, while employee benefits expense was at Rs 134.28 crore, dipping slightly 0.65% YoY.
For the TTM ended FY26, revenue from operations grew marginally by 2.98% to Rs 2170.93 crore, while net profit grew slightly 5.48% to Rs 281.42 crore, compared to previous TTM. EBITDA soared by 23865% to Rs 232.58 crore, and PBT saw a minor gain of 4.87% to Rs 374.6 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 200.45 crore in FY26, as against Rs 317.57 crore in FY25.
FDC Ltd tumbled by 19.96% in last one year, underperforming the benchmark BSE Sensex which has slipped by 13.18% during the same period.